The prediction and individualized treatment model of patients with PROC in the future....Compuscript Ltd
: Schematic representation of the underlying mechanisms of platinum resistance in ovarian cancer....Compuscript Ltd
Schematic depiction of the association between the platinum distribution in tumor cells and platinum resistance in ovari...Compuscript Ltd
FOLFIRINOX Shows Promise as Second-line Therapy for Advanced Biliary Tract Cancer...Pusan National University
MFAP2 promotes epithelial-mesenchymal transition (EMT) through the EGFR-AKT-STAT3 signaling pathway in colorectal cancer...Compuscript Ltd
MFAP2 is identified as a potential prognostic biomarker for colorectal cancer (CRC)....Compuscript Ltd
Proposed mechanism of MFAP2 promoting colorectal cancer (CRC) metastasis and drug resistance....Compuscript Ltd
